Published in Drug Alcohol Depend on February 01, 2008
Conditional Random Fields for Morphological Analysis of Wireless ECG Signals. ACM BCB (2016) 0.82
Bradycardia as a Marker of Chronic Cocaine Use: A Novel Cardiovascular Finding. Behav Med (2014) 0.75
Effects of disulfiram on QTc interval in non-opioid-dependent and methadone-treated cocaine-dependent patients. J Addict Med (2013) 0.75
Cocaine Hydrolase Gene Transfer Demonstrates Cardiac Safety and Efficacy against Cocaine-Induced QT Prolongation in Mice. J Pharmacol Exp Ther (2015) 0.75
Domain Adaptation Methods for Improving Lab-to-field Generalization of Cocaine Detection using Wearable ECG. Proc ACM Int Conf Ubiquitous Comput (2016) 0.75
Potential role of cardiac calsequestrin in the lethal arrhythmic effects of cocaine. Drug Alcohol Depend (2013) 0.75
Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry (1990) 1.54
Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry (2005) 1.48
Cocaine abuse: repolarization abnormalities and ventricular arrhythmias. Am J Med Sci (2000) 1.01
Cocaine-associated chest pain. Am J Med Sci (2002) 0.92
Cardiac and mood-related changes during short-term abstinence from crack cocaine: the identification of possible withdrawal phenomena. Am J Drug Alcohol Abuse (1999) 0.89
EEG absolute power during extended cocaine abstinence. J Addict Med (2007) 0.89
Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med (2010) 7.83
Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry (2006) 4.64
Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med (2004) 4.55
Why should addiction medicine be an attractive field for young physicians? Addiction (2008) 3.52
Introduction to behavioral addictions. Am J Drug Alcohol Abuse (2010) 3.22
Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors. Cancer Res (2008) 2.62
Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions. Clin Exp Metastasis (2008) 2.30
Use of a 'microecological technique' to study crime incidents around methadone maintenance treatment centers. Addiction (2012) 2.20
Elevated airborne exposures of teenagers to manganese, chromium, and iron from steel dust and New York City's subway system. Environ Sci Technol (2004) 2.18
Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci (2011) 2.05
Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict (2006) 1.94
Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy. Clin Exp Metastasis (2008) 1.94
Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med (2010) 1.92
The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule: do they diagnose the same smokers? Addict Behav (2002) 1.74
Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study. J Gastroenterol Hepatol (2012) 1.71
Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer. Mol Cancer Ther (2010) 1.70
Cannabinoids in exhaled breath following controlled administration of smoked cannabis. Clin Chem (2013) 1.67
Cocaine craving and use during daily life. Psychopharmacology (Berl) (2009) 1.62
On-site test for cannabinoids in oral fluid. Clin Chem (2012) 1.57
Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry (2005) 1.48
Effect of race on the timing of the Glenn and Fontan procedures for single-ventricle congenital heart disease. Pediatr Crit Care Med (2012) 1.48
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther (2004) 1.46
The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology (Berl) (2009) 1.42
Reliability and validity of a short form of the Marijuana Craving Questionnaire. Drug Alcohol Depend (2009) 1.42
Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug Alcohol Depend (2010) 1.39
Questions on conflict of interest. Am J Psychiatry (2010) 1.38
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology (Berl) (2007) 1.32
Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monit (2008) 1.29
A factor analysis of the Fagerström Test for Nicotine Dependence (FTND). Nicotine Tob Res (2003) 1.28
Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. Clin Chem (2009) 1.28
Steel dust in the New York City subway system as a source of manganese, chromium, and iron exposures for transit workers. J Urban Health (2005) 1.26
Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use. Am J Addict (2006) 1.21
Effect of rate of administration on subjective and physiological effects of intravenous cocaine in humans. Drug Alcohol Depend (2005) 1.20
Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clin Chem (2010) 1.19
Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clin Chem (2011) 1.18
Opioid abuse and cognitive performance. Drug Alcohol Depend (2004) 1.17
Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clin Chem (2014) 1.15
Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol (2004) 1.15
Conducting clinical research with prescription opioid dependence: defining the population. Am J Addict (2010) 1.10
Attentional bias towards cocaine-related stimuli: relationship to treatment-seeking for cocaine dependence. Am J Drug Alcohol Abuse (2007) 1.09
Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin Chem (2012) 1.09
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study. J Clin Psychopharmacol (2011) 1.08
State of the art treatments for cannabis dependence. Psychiatr Clin North Am (2012) 1.07
The second-oldest state psychiatric hospital in the United States. Am J Psychiatry (2014) 1.06
Calorie restriction increases cigarette use in adult smokers. Psychopharmacology (Berl) (2004) 1.06
Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biol Psychiatry (2010) 1.05
Pharmacological treatment of cannabis dependence. Curr Pharm Des (2011) 1.04
ADP-specific sensors enable universal assay of protein kinase activity. Chem Biol (2004) 1.04
Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers. Drug Test Anal (2014) 1.03
PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharmacol (2007) 1.02
Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration. J Clin Psychopharmacol (2008) 1.01
Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J Anal Toxicol (2006) 1.01
Strategies for quitting among non-treatment-seeking marijuana smokers. Am J Addict (2005) 1.00
Diagnostic criteria for cannabis withdrawal syndrome. Drug Alcohol Depend (2011) 1.00
A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. Pharmacoeconomics (2014) 0.99
Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction (2010) 0.98
Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal. Am J Drug Alcohol Abuse (2010) 0.98
Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence. Psychopharmacology (Berl) (2008) 0.97
Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. Clin Chim Acta (2012) 0.97
Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. population. Drug Alcohol Depend (2011) 0.97
Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial. Addict Biol (2008) 0.96
Cannabinoid stability in authentic oral fluid after controlled cannabis smoking. Clin Chem (2012) 0.95
Social determinants of health: an economic perspective. Health Econ (2009) 0.94
Non-β-cell progenitors of β-cells in pregnant mice. Organogenesis (2010) 0.94
Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. J Anal Toxicol (2012) 0.93
Recurrent delirium after surgery for congenital heart disease in an infant. Pediatr Crit Care Med (2011) 0.92
An accelerated pathway for targeted cancer therapies. Nat Rev Drug Discov (2011) 0.91
Histological criteria for grading of atypia in melanocytic conjunctival lesions. Pathology (2008) 0.91
Cost-effectiveness analysis of treatments for chronic disease: using R to incorporate time dependency of treatment response. Med Decis Making (2005) 0.91
Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. Anal Bioanal Chem (2013) 0.91
Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration. Anal Bioanal Chem (2011) 0.90
Intravenous butyrylcholinesterase administration and plasma and brain levels of cocaine and metabolites in rats. Eur J Pharmacol (2005) 0.90
Differential effects of trabecular meshwork stiffness on outflow facility in normal human and porcine eyes. Invest Ophthalmol Vis Sci (2012) 0.89
Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers? Clin Chem (2013) 0.89
Economic evaluation of coronary artery bypass grafting surgery with and without cardiopulmonary bypass: cost-effectiveness and quality-adjusted life years in a randomized controlled trial. Artif Organs (2008) 0.89
Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial. Schizophr Res (2011) 0.89
EEG absolute power during extended cocaine abstinence. J Addict Med (2007) 0.89
A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview. Contemp Clin Trials (2010) 0.88
Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis. Rheumatology (Oxford) (2011) 0.87
Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices. Drug Metab Rev (2015) 0.87
Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration. Clin Chem (2011) 0.86
Motivations to quit cannabis use in an adult non-treatment sample: are they related to relapse? Addict Behav (2013) 0.86
Spending of remuneration by subjects in non-treatment drug abuse research studies. Am J Drug Alcohol Abuse (2006) 0.85
Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment. Am J Addict (2014) 0.84
In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis. Anal Bioanal Chem (2013) 0.84
Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model. Med Decis Making (2005) 0.84
MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration. Ther Drug Monit (2011) 0.84
Influence of psychotherapy attendance on buprenorphine treatment outcome. J Subst Abuse Treat (2005) 0.84